Results 11 to 20 of about 5,373,856 (290)

Parkinson Disease [PDF]

open access: yesMayo Clinic Proceedings, 2016
Parkinson disease (PD) is a progressive neurodegenerative disease that affects one million people in the United States. This article reviews the etiology and pathophysiology of PD, risk factors, clinical manifestations, diagnostic criteria, and treatment of this common disease. Implications for home care clinicians are included.
Rachael A, Vaubel   +2 more
  +7 more sources

Is restless legs syndrome in Parkinson disease patients associated with any specific factor? [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2021
Background: Restless legs syndrome or Willis-Ekbom disease is a disorder characterized by unpleasant sensations associated with the need to mobilize the lower limbs.
Manoel Alves SOBREIRA-NETO   +7 more
doaj   +1 more source

Stability of MDS-UPDRS Motor Subtypes Over Three Years in Early Parkinson's Disease

open access: yesFrontiers in Neurology, 2021
Background: Various classifications have been proposed to subtype Parkinson's disease (PD) based on their motor phenotypes. However, the stability of these subtypes has not been properly evaluated.Objective: The goal of this study was to understand the ...
Abhijeet K. Kohat   +33 more
doaj   +1 more source

Slow wave activity across sleep-night could predict levodopa-induced dyskinesia

open access: yesScientific Reports, 2023
A disruption in the slow wave activity (SWA) mediated synaptic downscaling process features Parkinson's disease (PD) patients presenting levodopa-induced dyskinesia (LID).
Ninfa Amato   +5 more
doaj   +1 more source

Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease

open access: yesNature Communications, 2023
Little is known about circular RNAs (circRNAs) in specific brain cells and human neuropsychiatric disease. Here, we systematically identify over 11,039 circRNAs expressed in vulnerable dopamine and pyramidal neurons laser-captured from 190 human brains ...
Xianjun Dong   +11 more
doaj   +1 more source

Parkinson Disease Subtype Stability and Eventual Convergence. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Objective Previous research identified distinct Parkinson disease (PD) clinical subtypes of “Motor Only,” “Psychiatric & Motor,” and “Cognitive & Motor” based on comprehensive, multidomain classification. Whether these subtypes reflect distinct trajectories or progressive disease stages remains unknown.
Rosok LM   +10 more
europepmc   +2 more sources

Familial Parkinson’s Disease/Parkinsonism [PDF]

open access: yesBioMed Research International, 2015
Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by parkinsonism (bradykinesia, resting tremor, rigidity, and postural instability) with good response to L-dopa. Although the majority of PD patients are sporadic, it is now clear that genetic factors contribute to the pathogenesis of PD.
Hiroyuki Tomiyama   +3 more
openaire   +2 more sources

Patient-Centric Care for Parkinson's Disease: From Hospital to the Community

open access: yesFrontiers in Neurology, 2020
Parkinson's disease (PD) is a chronic neurodegenerative disease with complex motor and non-motor symptoms often leading to significant caregiver burden.
Yin Minn Aye   +27 more
doaj   +1 more source

Parkinson's disease [PDF]

open access: yesThe Lancet, 2021
Parkinson's disease is a recognisable clinical syndrome with a range of causes and clinical presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; the rising prevalence worldwide resembles the many characteristics typically observed during a pandemic, except for an infectious cause.
Bloem, B.R., Okun, M.S., Klein, C.
openaire   +2 more sources

Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease

open access: yesnpj Parkinson's Disease, 2023
The LRRK2 G2019S pathogenic mutation causes LRRK2-associated Parkinson’s disease (L2PD) with incomplete penetrance. LRRK2 non-manifesting carriers (L2NMC) are at PD high risk but predicting pheno-conversion is challenging given the lack of progression ...
Marta Soto   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy